Opus Genetics | DFAN14A: Definitive additional proxy soliciting materials filed by non-management
Opus Genetics | 8-K: Current report
Opus Genetics | 8-K: Current report
Opus Genetics | 8-K: Current report
Opus Genetics | 8-K/A: Current report (Amendment)
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | DEFR14A: Definitive proxy statement in connection with contested solicitations
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | DEF 14A: Definitive information statements
Ocuphire Pharma | DEFA14A: Others
Ocuphire Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ocuphire Pharma | S-3: Registration statement for specified transactions by certain issuers
Ocuphire Pharma | 8-K: Current report
Ocuphire Pharma | 8-K: Current report